A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain Barrier

Martin Bauer (Corresponding author), Rudolf Karch, Beatrix Wulkersdorfer, Cecile Philippe, Lukas Nics, Eva-Maria Klebermass, Maria Weber, Stefan Poschner, Helmuth Haslacher, Walter Jäger, Nicolas Tournier, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger, Oliver Langer

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Pages (from-to)486-491
    Number of pages6
    JournalThe Journal of Nuclear Medicine
    Volume60
    Issue number4
    Early online date20 Sept 2018
    DOIs
    Publication statusPublished - Apr 2019

    Austrian Fields of Science 2012

    • 301207 Pharmaceutical chemistry

    Keywords

    • ABCB1
    • BINDING
    • C-11-erlotinib
    • CANCER RESISTANCE PROTEIN
    • ELACRIDAR
    • ERLOTINIB
    • METASTASES
    • P-GLYCOPROTEIN
    • P-glycoprotein
    • PET
    • SUBFAMILY-B MEMBER-1
    • TUMOR BARRIER
    • blood-brain barrier
    • breast cancer resistance protein
    • Breast cancer resistance protein
    • Blood–brain barrier
    • C-erlotinib

    Cite this